Meg Haney - Publications

Affiliations: 
Psychiatry Columbia University, New York, NY 
Area:
Addiction Research

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse. Addiction Biology. PMID 30378231 DOI: 10.1111/Adb.12664  0.683
2018 Haney M, Cooper ZD, Bedi G, Herrmann E, Comer SD, Reed SC, Foltin RW, Levin FR. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. Addiction Biology. PMID 29659126 DOI: 10.1111/Adb.12621  0.652
2018 Cooper ZD, Bedi G, Ramesh D, Balter R, Comer SD, Haney M. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29463913 DOI: 10.1038/S41386-018-0011-2  0.53
2017 Neelakantan H, Holliday ED, Fox RG, Stutz SJ, Comer SD, Haney M, Anastasio NC, Moeller FG, Cunningham KA. Lorcaserin suppresses oxycodone self-administration and relapse vulnerability in rats. Acs Chemical Neuroscience. PMID 28107783 DOI: 10.1021/Acschemneuro.6B00413  0.509
2017 Herrmann ES, Cooper Z, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin R, Haney M. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and relapse among non-treatment-seeking cannabis users Drug and Alcohol Dependence. 171: e88. DOI: 10.1016/J.Drugalcdep.2016.08.247  0.685
2016 Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users. Psychopharmacology. PMID 27085870 DOI: 10.1007/S00213-016-4298-6  0.683
2015 Haney M, Malcolm RJ, Babalonis S, Nuzzo PA, Cooper ZD, Bedi G, Gray KM, McRae-Clark A, Lofwall MR, Sparenborg S, Walsh SL. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26708108 DOI: 10.1038/Npp.2015.367  0.302
2015 Haney M, Ramesh D, Glass A, Pavlicova M, Bedi G, Cooper ZD. Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25881117 DOI: 10.1038/Npp.2015.108  0.569
2014 Ramesh D, Haney M, Cooper ZD. Dose-dependent physiological and subjective effects of marijuana in daily marijuana smokers Drug and Alcohol Dependence. 140: e181-e182. DOI: 10.1016/J.Drugalcdep.2014.02.509  0.507
2013 Ramesh D, Haney M, Cooper ZD. Marijuana's dose-dependent effects in daily marijuana smokers. Experimental and Clinical Psychopharmacology. 21: 287-93. PMID 23937597 DOI: 10.1037/A0033661  0.527
2013 Haney M, Cooper ZD, Bedi G, Vosburg SK, Comer SD, Foltin RW. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1557-65. PMID 23443718 DOI: 10.1038/Npp.2013.54  0.304
2005 Hart CL, Haney M, Vosburg SK, Comer SD, Foltin RW. Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure. Psychopharmacology. 181: 237-43. PMID 15830233 DOI: 10.1007/s00213-005-2234-2  0.301
1995 Haney M, Miczek KA. Delta opioid receptors: reflexive, defensive and vocal affective responses in female rats. Psychopharmacology. 121: 204-12. PMID 8545526 DOI: 10.1007/Bf02245631  0.513
1994 Miczek KA, Weerts E, Haney M, Tidey J. Neurobiological mechanisms controlling aggression: preclinical developments for pharmacotherapeutic interventions. Neuroscience and Biobehavioral Reviews. 18: 97-110. PMID 8170625 DOI: 10.1016/0149-7634(94)90040-X  0.679
1994 Miczek KA, Haney M. Psychomotor stimulant effects of d-amphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice. Psychopharmacology. 115: 358-65. PMID 7871076 DOI: 10.1007/Bf02245077  0.482
1994 Haney M, Miczek KA. Ultrasounds emitted by female rats during agonistic interactions: effects of morphine and naltrexone. Psychopharmacology. 114: 441-8. PMID 7855202 DOI: 10.1007/Bf02249334  0.493
1993 Haney M, Miczek KA. Ultrasounds during agonistic interactions between female rats (Rattus norvegicus). Journal of Comparative Psychology (Washington, D.C. : 1983). 107: 373-9. PMID 8112049 DOI: 10.1037/0735-7036.107.4.373  0.44
1991 Vivian J, Haney M, Miczek K. Opioid suppression of male and female ultra sounds during social defeat Pharmacology Biochemistry and Behavior. 39: 246. DOI: 10.1016/0091-3057(91)90537-C  0.419
1990 Kumar AM, Haney M, Becker T, Thompson ML, Kream RM, Miczek K. Effect of early exposure to delta-9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropin-releasing hormone and substance P in the adult male rat brain. Brain Research. 525: 78-83. PMID 1700926 DOI: 10.1016/0006-8993(90)91322-8  0.478
1990 Haney M, Miczek KA. Aggression attenuates psychomotor stimulant effects of d-amphetamine, MDMA and PCP Pharmacology Biochemistry and Behavior. 36: 439. DOI: 10.1016/0091-3057(90)90512-G  0.426
1989 Miczek KA, Haney M, Tidey J, Vatne T, Weerts E, DeBold JF. Temporal and sequential patterns of agonistic behavior: effects of alcohol, anxiolytics and psychomotor stimulants. Psychopharmacology. 97: 149-51. PMID 2567022 DOI: 10.1007/Bf00442237  0.673
1989 Haney M, Miczek KA. Morphine effects on maternal aggression, pup care and analgesia in mice. Psychopharmacology. 98: 68-74. PMID 2498961 DOI: 10.1007/Bf00442008  0.493
Show low-probability matches.